We are pleased to announce that the Translational Andrology and Urology (TAU) has attained its latest impact factor for the 2025 citation year: 1.9 (Figure 1).
Figure 1 Journal Impact Factor of TAU
Translational Andrology and Urology (Print ISSN 2223-4683; Online ISSN 2223-4691; Transl Androl Urol; TAU) is published by AME Publishing Company, with support from Wolters Kluwer (the journal content will be made available on Wolters Kluwer Health’s Lippincott and Ovid platforms). It is an open-access, peer-reviewed, monthly journal (quarterly published from Mar. 2012 to Dec. 2014; bimonthly published from Jan. 2015 to Dec. 2020). TAU delivers up-to-date findings and provides current and practical information on basic and clinical research of andrology and urology. It publishes articles that cover various aspects in diseases of male and female urinary tract including kidneys, ureters, bladder, and urethra, and the male reproductive organs like penis, testes, scrotum, prostate, etc. Contributions pertinent to urology and andrology are also included from related fields such as public health, basic sciences, education, sociology, and nursing. TAU has been indexed by PubMed/PubMed Central, Scopus, and Web of Science [Science Citation Index Expanded (SCIE)]. Meanwhile, TAU is endorsed by the Genitourinary Medical Association of China International Exchange and Promotive Association for Medical and Health Care (GUA-CPAM).
We strive to follow the best practices in publishing. The announcement of the journal’s latest impact factor is not only a significant achievement for the journal but also a recognition of its more significant scientific reach. Here, we would like to extend our heartfelt gratitude to all our Editorial Board Members, Guest Editors, Authors, and Reviewers for their significant contributions.
We look forward to the continuous cooperation with all the individuals mentioned above and those who are interested in related fields to bring more exciting content to readers in the future.
2025 Journal Impact Factors of AME journals
We are also pleased to share the latest impact factors of all journals published under AME Publishing Company (Table 1).
- 37 AME journals received a Journal Impact Factor (JIF) this year, with three journals receiving their first JIF
- 12 journals have one or more categories ranked in Q1 or Q2
These achievements reflect the continuous growth and academic influence of our journal portfolio. We sincerely thank all contributors across our journals for their dedication and support.
Table 1 2025 Journal Impact Factors of AME journals
Editorial Office
Translational Andrology and Urology